15-43599215-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001375484.1(CKMT1B):c.1196G>A(p.Arg399His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00688 in 1,613,626 control chromosomes in the GnomAD database, including 191 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0059 ( 17 hom., cov: 30)
Exomes 𝑓: 0.0070 ( 174 hom. )
Consequence
CKMT1B
NM_001375484.1 missense
NM_001375484.1 missense
Scores
1
5
8
Clinical Significance
Conservation
PhyloP100: 2.52
Genes affected
CKMT1B (HGNC:1995): (creatine kinase, mitochondrial 1B) Mitochondrial creatine (MtCK) kinase is responsible for the transfer of high energy phosphate from mitochondria to the cytosolic carrier, creatine. It belongs to the creatine kinase isoenzyme family. It exists as two isoenzymes, sarcomeric MtCK and ubiquitous MtCK, encoded by separate genes. Mitochondrial creatine kinase occurs in two different oligomeric forms: dimers and octamers, in contrast to the exclusively dimeric cytosolic creatine kinase isoenzymes. Many malignant cancers with poor prognosis have shown overexpression of ubiquitous mitochondrial creatine kinase; this may be related to high energy turnover and failure to eliminate cancer cells via apoptosis. Ubiquitous mitochondrial creatine kinase has 80% homology with the coding exons of sarcomeric mitochondrial creatine kinase. Two genes located near each other on chromosome 15 have been identified which encode identical mitochondrial creatine kinase proteins. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012996405).
BP6
Variant 15-43599215-G-A is Benign according to our data. Variant chr15-43599215-G-A is described in ClinVar as [Benign]. Clinvar id is 778548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00589 (895/151904) while in subpopulation SAS AF= 0.0219 (105/4802). AF 95% confidence interval is 0.0185. There are 17 homozygotes in gnomad4. There are 445 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 17 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CKMT1B | NM_001375484.1 | c.1196G>A | p.Arg399His | missense_variant | 9/9 | ENST00000441322.6 | NP_001362413.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CKMT1B | ENST00000441322.6 | c.1196G>A | p.Arg399His | missense_variant | 9/9 | 1 | NM_001375484.1 | ENSP00000413255 | P1 | |
CKMT1B | ENST00000300283.10 | c.1196G>A | p.Arg399His | missense_variant | 10/10 | 5 | ENSP00000300283 | P1 | ||
CKMT1B | ENST00000437534.3 | c.*1116G>A | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 2 | ENSP00000416717 |
Frequencies
GnomAD3 genomes AF: 0.00581 AC: 882AN: 151788Hom.: 15 Cov.: 30
GnomAD3 genomes
AF:
AC:
882
AN:
151788
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00623 AC: 1567AN: 251408Hom.: 31 AF XY: 0.00729 AC XY: 990AN XY: 135878
GnomAD3 exomes
AF:
AC:
1567
AN:
251408
Hom.:
AF XY:
AC XY:
990
AN XY:
135878
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00698 AC: 10209AN: 1461722Hom.: 174 Cov.: 32 AF XY: 0.00747 AC XY: 5434AN XY: 727166
GnomAD4 exome
AF:
AC:
10209
AN:
1461722
Hom.:
Cov.:
32
AF XY:
AC XY:
5434
AN XY:
727166
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00589 AC: 895AN: 151904Hom.: 17 Cov.: 30 AF XY: 0.00599 AC XY: 445AN XY: 74266
GnomAD4 genome
AF:
AC:
895
AN:
151904
Hom.:
Cov.:
30
AF XY:
AC XY:
445
AN XY:
74266
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
18
ESP6500EA
AF:
AC:
61
ExAC
AF:
AC:
816
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 02, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at